The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(2-(1-(2-methoxyethyl)-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-(pyridin-4-ylmethyl)urea ID: ALA4877360
PubChem CID: 164626220
Max Phase: Preclinical
Molecular Formula: C19H20N8O2
Molecular Weight: 392.42
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COCCn1nccc1-c1nc2ccc(NC(=O)NCc3ccncc3)cn2n1
Standard InChI: InChI=1S/C19H20N8O2/c1-29-11-10-26-16(6-9-22-26)18-24-17-3-2-15(13-27(17)25-18)23-19(28)21-12-14-4-7-20-8-5-14/h2-9,13H,10-12H2,1H3,(H2,21,23,28)
Standard InChI Key: JDVBQNXXVMKQMB-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
26.8724 -4.9238 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.5801 -4.5152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2878 -4.9238 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.0019 -4.5110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1647 -4.5152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5801 -3.6980 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.4570 -4.9238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7498 -4.5121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0426 -4.9200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0422 -5.7381 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.7548 -6.1465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4592 -5.7362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7046 -4.9212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7068 -3.2877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9950 -3.6945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4144 -3.6985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4111 -4.5152 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.1868 -4.7708 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.6696 -4.1120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1921 -3.4494 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.4795 -4.1076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9584 -4.7576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7274 -4.5032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7230 -3.6932 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.9514 -3.4472 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.6937 -2.6717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2364 -2.0607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0369 -2.2253 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.2946 -3.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
1 5 1 0
2 6 2 0
5 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
4 13 2 0
4 15 1 0
13 17 1 0
16 14 1 0
14 15 2 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 16 2 0
19 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 21 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 392.42Molecular Weight (Monoisotopic): 392.1709AlogP: 1.96#Rotatable Bonds: 7Polar Surface Area: 111.26Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.12CX Basic pKa: 5.02CX LogP: 1.52CX LogD: 1.52Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.50Np Likeness Score: -2.40
References 1. Akiu M, Tsuji T, Sogawa Y, Terayama K, Yokoyama M, Tanaka J, Asano D, Sakurai K, Sergienko E, Sessions EH, Gardell SJ, Pinkerton AB, Nakamura T.. (2021) Discovery of 1-[2-(1-methyl-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-3-(pyridin-4-ylmethyl)urea as a potent NAMPT (nicotinamide phosphoribosyltransferase) activator with attenuated CYP inhibition., 43 [PMID:33887438 ] [10.1016/j.bmcl.2021.128048 ]